日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity

达沙替尼和曲美替尼促进抗肿瘤代谢活性

Eric L Bolf, Thomas C Beadnell, Madison M Rose, Angelo D'Alessandro, Travis Nemkov, Kirk C Hansen, Rebecca E Schweppe

TRβ Agonism Induces Tumor Suppression and Enhances Drug Efficacy in Anaplastic Thyroid Cancer in Female Mice

TRβ 激动剂可抑制雌性小鼠的肿瘤并增强其对未分化甲状腺癌的药物疗效

Noelle E Gillis, Lauren M Cozzens, Emily R Wilson, Noah M Smith, Jennifer A Tomczak, Eric L Bolf, Frances E Carr

Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells

乳腺癌和甲状腺癌细胞中甲状腺激素受体β的常见肿瘤抑制信号

Eric L Bolf, Noelle E Gillis, Cole D Davidson, Lauren M Cozzens, Sophie Kogut, Jennifer A Tomczak, Seth Frietze, Frances E Carr

Thyroid Hormone Receptor Beta Inhibits PI3K-Akt-mTOR Signaling Axis in Anaplastic Thyroid Cancer via Genomic Mechanisms

甲状腺激素受体 β 通过基因组机制抑制甲状腺未分化癌中的 PI3K-Akt-mTOR 信号轴

Cole D Davidson, Eric L Bolf, Noelle E Gillis, Lauren M Cozzens, Jennifer A Tomczak, Frances E Carr

The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer

甲状腺激素受体-RUNX2 轴:乳腺癌中的一种新型肿瘤抑制途径

Eric L Bolf, Noelle E Gillis, Michael S Barnum, Caitlin M Beaudet, Grace Y Yu, Jennifer A Tomczak, Janet L Stein, Jane B Lian, Gary S Stein, Frances E Carr

Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling

甲状腺激素受体β对RUNX2的抑制是由Brahma相关基因1依赖的染色质重塑介导的

Noelle E Gillis ,Thomas H Taber ,Eric L Bolf ,Caitlin M Beaudet ,Jennifer A Tomczak ,Jeffrey H White ,Janet L Stein ,Gary S Stein ,Jane B Lian ,Seth Frietze ,Frances E Carr